How to design a phase I trial of an anticancer botanical.
about
Which botanicals or other unconventional anticancer agents should we take to clinical trial?A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effectsA first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.
P2860
How to design a phase I trial of an anticancer botanical.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
How to design a phase I trial of an anticancer botanical.
@ast
How to design a phase I trial of an anticancer botanical.
@en
How to design a phase I trial of an anticancer botanical.
@nl
type
label
How to design a phase I trial of an anticancer botanical.
@ast
How to design a phase I trial of an anticancer botanical.
@en
How to design a phase I trial of an anticancer botanical.
@nl
prefLabel
How to design a phase I trial of an anticancer botanical.
@ast
How to design a phase I trial of an anticancer botanical.
@en
How to design a phase I trial of an anticancer botanical.
@nl
P2860
P1476
How to design a phase I trial of an anticancer botanical
@en
P2093
Andrew J Vickers
P2860
P577
2006-01-01T00:00:00Z